Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02930759 · ClinicalTrials.gov registry record · NA

Sun Protection Factor Assay (SPF Assay 200/2016)

A NA study of Sunscreening Agents, sponsored by Bayer.

Completed
Registry status
NA
Development phase
3
Enrollment target
1
Study location

NCT02930759 is a NA study of Sunscreening Agents that has completed, run by Bayer. The registered enrollment target is 3 participants, below the 81-participant average among 21 other Sunscreening Agents trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02930759, a NA study of Sunscreening Agents, has completed, sponsored by Bayer.

COMPLETED
Registry status
NA
Development phase
3 participants
Enrollment target
1
Study location

Study Summary

To evaluate the Sun Protection Factor efficacy on human skin.

Conditions Studied

Interventions

  • DRUG BAY987516

Study Locations (1)

New Jersey

  • - Union

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2016-10-12
Est. Completion 2016-10-13
Phase NA

Sponsor

Bayer

591 total trials

What the Registry Record Tells You About NCT02930759

The ClinicalTrials.gov registry entry for NCT02930759 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 81-participant average among 21 other Sunscreening Agents trials with a reported enrollment target (96% lower). The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sunscreening Agents appearing as the primary indexed condition, and to 1 intervention - of which BAY987516 is the first listed.

NCT02930759 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT02930759 about?

NCT02930759 is a clinical study titled "Sun Protection Factor Assay (SPF Assay 200/2016)". To evaluate the Sun Protection Factor efficacy on human skin.

What is the current status of trial NCT02930759?

This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2016-10-12. Estimated completion is 2016-10-13.

What conditions does trial NCT02930759 study?

This clinical trial studies the following conditions: Sunscreening Agents.

What interventions are being tested in trial NCT02930759?

The interventions under investigation include: BAY987516 (DRUG).

Who is sponsoring clinical trial NCT02930759?

This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02930759 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sunscreening Agents

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.